The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
Open accessAbstract
Omega-3 fatty acids (omega-3 FAs), DHA and EPA, exert anti-inflammatory effects, but the mechanisms are poorly understood. Here, we show that the G protein-coupled receptor 120 (GPR120) functions as an omega-3 FA receptor/sensor. Stimulation of GPR120 with omega-3 FAs or a chemical agonist causes broad anti-inflammatory effects in monocytic RAW 264.7 cells and in primary intraperitoneal macrophages. All of these effects are abrogated by GPR120 knockdown. Since chronic macrophage-mediated tissue inflammation is a key mechanism for insulin resistance in obesity, we fed obese WT and GPR120 knockout mice a high-fat diet with or without omega-3 FA supplementation. The omega-3 FA treatment inhibited inflammation and enhanced systemic insulin sensitivity in WT mice, but was without effect in GPR120 knockout mice. In conclusion, GPR120 is a functional omega-3 FA receptor/sensor and mediates potent insulin sensitizing and antidiabetic effects in vivo by repressing macrophage-induced tissue inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The anti-inflammatory effects of omega-3 fatty acids seems to be mediated by binding to the G-protein–coupled receptor 120 and inhibition of NLRP3 inflammasome activity (53,54).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [53]
In the citing paper
“in macrophages and adipocytes the G-protein coupled receptor GPR120 is an omega-3 sensitive receptor that exhibits anti-inflammatory properties through the suppression of TNF-activation [141]”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [141]
In the citing paper
“GPR120 expression is negligible in skeletal muscle and would therefore not explain the changes induced by omega-3 PUFAs in tissue culture models [141]”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [141]
In the citing paper
“In summary, the n-3 PUFAs EPA and DHA can reduce inflammation via their incorporation into membrane phospholipids, where they inhibit the production of pro-inflammatory eicosanoids, reducing of activation of immune cells and the associated release of pro-inflammatory cytokines [71,97,98].”
From Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration (2018) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 2×
“Consistent with previous studies (Weisberg et al., 2003; Xu et al., 2003; Nguyen et al., 2007), HFD induced a large increase in F4/80 positive ATMs, which form crown-like structures (CLS) around adipocytes in both WT and GPR120 KO mice.”
InfluentialXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Kawai, T., & Akira, S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,894
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · cited 4×
“Since chronic tissue inflammation is an important mechanism causing insulin resistance (Xu et al., 2003; Shoelson et al., 2007; Schenk et al., 2008), the anti-inflammatory actions of u-3 FAs exert potent insulin sensitizing effects.”
InfluentialFree fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2004) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,580 · cited 4×
“Long-chain FAs can activate GPR40 (Itoh et al., 2003) and GPR120 (Hirasawa et al., 2005).”
InfluentialFree fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538 · cited 6×
“Recently, several groups reported that five orphan receptors, GPR40, GPR41, GPR43, GPR84, and GPR120, can be activated by free fatty acids (FFAs).”
Influentialβ-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473 · cited 1×
“Interestingly, only the full-length b-arrestin2 coprecipitated with GPR120 and TAB1, while a series of deletion/truncation b-arrestin2 mutants did not, indicating that the interactions are dependent on the complete tertiary structure of b-arrestin2 (Figure S2D; Luttrell et al., 1999).”
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Gether, U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0390 · Cited by 1,264 · cited 1×
“…to GPCRs to stimulate and induce a variety of cellular responses via several second messenger pathways; e.g., modulation of cAMP production, the phospholipase C pathway, ion channels, and mitogen-activated protein kinases (Ulloa-Aguirre et al., 1999; Gether, 2000; Schulte and Fredholm, 2003.”
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 5×
“Since chronic macrophage-mediated tissue inflammation is a key mechanism for insulin resistance in obesity, we fed obese WT and GPR120 knockout mice a high-fat diet with or without u-3 FA supplementation.”
InfluentialSelf-citation
Cited by
Sorted by citations
Items 301–400 of 1,006
Postbiotics in human health: Possible new functional ingredients?
Hernández-Granados, M. J., & Franco‐Robles, E. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109660 · Cited by 122
Polyunsaturated fatty acids and endocannabinoids in health and disease
Freitas, H. R., Isaac, A. R., Malcher‐Lopes, R., Diaz, B. L., Trevenzoli, I. H., & Reis, R. A. D. M. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1347373 · Cited by 118
Li, Y., Zhang, H., Jiang, C., Xu, M., Pang, Y., Feng, J., Xiang, X., Kong, W., Xu, G., Li, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431627 · Cited by 116
Kromhout, D., Geleijnse, J. M., de Goede, J., Griep, L. M. O., Mulder, B. J. M., de Boer, M., Deckers, J. W., Boersma, E. H., Zock, P. L., & Giltay, E. J. (2011) · Diabetes Care · doi:10.2337/dc11-0896 · Cited by 116
Therapeutic potentials and modulatory mechanisms of fatty acids in bone
Bao, M., Zhang, K., Wei, Y., Hua, W., Gao, Y., Li, X., & Ye, L. (2019) · Cell Proliferation · doi:10.1111/cpr.12735 · Cited by 120
The Baseline Gut Microbiota Directs Dieting-Induced Weight Loss Trajectories
Jie, Z., Yu, X., Liu, Y., Sun, L., Chen, P., Ding, Q., Gao, Y., Zhang, X., Yu, M., Liu, Y., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.029 · Cited by 118
Genetics of nonalcoholic fatty liver disease
Dongiovanni, P., & Valenti, L. V. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.018 · Cited by 118
Virtanen, J. K., Mursu, J., Voutilainen, S., Uusitupa, M. I. J., & Tuomainen, T. (2013) · Diabetes Care · doi:10.2337/dc13-1504 · Cited by 121
Liu, Y., Chen, L., Sokołowska, M., Eberlein, M. H., Alsaaty, S., Martínez‐Antón, A., Logun, C., Qi, H., & Shelhamer, J. H. (2014) · Immunology · doi:10.1111/imm.12296 · Cited by 118
Christiansen, E., Watterson, K. R., Stocker, C. J., Sokol, E., Jenkins, L., Simon, K., Grundmann, M., Petersen, R. K., Wargent, E. T., Hudson, B. D., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s000711451500118x · Cited by 116
Moniri, N. H. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.021 · Cited by 115
Jin, J., Duan, J., Du, L., Xing, W., Peng, X., & Zhao, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1027756 · Cited by 120
Ulven, T., & Christiansen, E. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034410 · Cited by 119
Role and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 117
Balvers, M. G. J., Verhoeckx, K. C. M., Bijlsma, S., Rubingh, C. M., Meijerink, J., Wortelboer, H. M., & Witkamp, R. F. (2012) · Metabolomics · doi:10.1007/s11306-012-0421-9 · Cited by 114
Extrasensory perception: Odorant and taste receptors beyond the nose and mouth
Foster, S. R., Roura, E., & Thomas, W. G. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.004 · Cited by 117
Hudson, B. D., Due‐Hansen, M. E., Christiansen, E., Hansen, A. M., Mackenzie, A. E., Murdoch, H., Pandey, S. K., Ward, R. J., Márquez, R., Tikhonova, I. G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455337 · Cited by 111
López‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 114
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
Grundmann, M., Bender, E., Schamberger, J., & Eitner, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041763 · Cited by 113
Bioactive metabolites of docosahexaenoic acid
Kuda, O. (2017) · Biochimie · doi:10.1016/j.biochi.2017.01.002 · Cited by 116
Heerwagen, M. J. R., Stewart, M. S., de la Houssaye, B. A., Janssen, R. C., & Friedman, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067791 · Cited by 116
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014373 · Cited by 108
Wellhauser, L., & Belsham, D. D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-60 · Cited by 108
Lim, J., Iyer, A., Liu, L., Suen, J. Y., Lohman, R., Seow, V., Yau, M., Brown, L., & Fairlie, D. P. (2013) · The FASEB Journal · doi:10.1096/fj.13-232702 · Cited by 110
G protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 110
Self-citationAbshirini, M., Ilesanmi-Oyelere, B. L., & Kruger, M. C. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101113 · Cited by 114
Yang, X., Deng, B., Zhao, W., Guo, Y., Wan, Y., Wu, Z., Su, S., Gu, J., Hu, X., Feng, W., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.029 · Cited by 111
Polyunsaturated Fatty Acids in Inflammatory Bowel Diseases
Marion‐Letellier, R., Savoye, G., Beck, P. L., Panaccione, R., & Ghosh, S. K. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182810122 · Cited by 110
Jayarathne, S., Koboziev, I., Park, O., Oldewage-Theron, W. H., Shen, C., & Moustaïd‐Moussa, N. (2017) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2017.22.4.251 · Cited by 110
Inflammatory Signaling and Brown Fat Activity
Omran, F., & Christian, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00156 · Cited by 111
“Importantly, GPR120 mediates the anti-inflammatory and insulin sensitizing effects of ω3-FAs including inhibition of inflammatory pathways and cytokine secretion in adipocytes and macrophages (215, 216).”
CD36‐dependent signaling mediates fatty acid‐induced gut release of secretin and cholecystokinin
Sundaresan, S., Shahid, R. A., Riehl, T. E., Chandra, R., Nassir, F., Stenson, W. F., Liddle, R. A., & Abumrad, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-217703 · Cited by 112
Martin, C., Passilly‐Degrace, P., Chevrot, M., Ancel, D., Sparks, S. M., Drucker, D. J., & Besnard, P. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m025874 · Cited by 111
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
Milligan, G., Alvarez‐Curto, E., Hudson, B. D., Prihandoko, R., & Tobin, A. B. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.06.006 · Cited by 113
GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids
Raptis, D. A., Limani, P., Jang, J. H., Ungethüm, U., Tschuor, C., Graf, R., Humar, B., & Clavien, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.006 · Cited by 108
Soleimani, Z., Hashemdokht, F., Bahmani, F., Taghizadeh, M., Memarzadeh, M. R., & Asemi, Z. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.06.010 · Cited by 107
Considerations and guidelines for mouse metabolic phenotyping in diabetes research
Alquier, T., & Poitout, V. (2017) · Diabetologia · doi:10.1007/s00125-017-4495-9 · Cited by 106
Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges
Ghislain, J. J., & Poitout, V. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00459-w · Cited by 110
Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?
Michael-Titus, A. T., & Priestley, J. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.005 · Cited by 108
Marine natural products with anti-inflammatory activity
Cheung, R. C. F., Ng, T. B., Wong, J. H., Chen, Y., & Chan, W. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7244-3 · Cited by 112
Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer
Volpato, M., & Hull, M. A. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9744-y · Cited by 107
“[40], on which activation can alter macrophage polarisation and reduce inflammation that is potentially important for anticancer activity of O3FAs.”
Zaloga, G. P. (2021) · Nutrients · doi:10.3390/nu13020662 · Cited by 113
“Oh [19] Murine macrophages and adipocytes Decreased TNFα, IL-6, MCP-1, IL-1β; increased IL-10”
Long chain fatty acids and gene expression in inflammation and immunity
Calder, P. C. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283620616 · Cited by 106
β-Arrestin 2 Mediates G Protein-Coupled Receptor 43 Signals to Nuclear Factor-κB
Lee, S. U., In, H. J., Kwon, M. S., Park, B.-O., Jo, M., Kim, M.-O., Cho, S., Lee, S., Lee, H., Kwak, Y. S., et al. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00312 · Cited by 109
Omega-3 Polyunsaturated Fatty Acids and Cancer
Jing, K., Wu, T., & Lim, K. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990319 · Cited by 110
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism
Naughton, S., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · International Journal of Endocrinology · doi:10.1155/2013/361895 · Cited by 109
The role of dietary fatty acid intake in inflammatory gene expression: a critical review
Rocha, D. M. U. P., Bressan, J., & Hermsdorff, H. H. M. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.008607072016 · Cited by 108
Albert, B. B., Derraik, J. G. B., Brennan, C. M., Biggs, J. B., Smith, G. C., Garg, M. L., Cameron-Smith, D., Hofman, P. L., & Cutfield, W. S. (2014) · Scientific Reports · doi:10.1038/srep06697 · Cited by 105
Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration
Tachtsis, B., Camera, D., & Lacham-Kaplan, O. (2018) · Nutrients · doi:10.3390/nu10030309 · Cited by 104
Lin, C., Chao, H., Li, Z., Xu, X., Liu, Y., Bao, Z., Hou, L., Liu, Y., Wang, X., You, Y., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.005 · Cited by 103
Pillaiyar, T., Köse, M., Sylvester, K., Weighardt, H., Thimm, D., Borges, G., Förster, I., von Kügelgen, I., & Müller, C. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01593 · Cited by 107
Cao, W., Wang, C., Chin, Y., Chen, X., Gao, Y., Yuan, S., Xue, C., Wang, Y., & Tang, Q. (2018) · Food & Function · doi:10.1039/c8fo01404c · Cited by 104
Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases
Abdolmaleki, F., Kovanen, P. T., Mardani, R., Hayat, S. M. G., Bo, S., & Sahebkar, A. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08754-9 · Cited by 104
“It can be thus concluded that PUFAs and derivatives thereof, such as the anti-inflammatory and cytoprotective resolvins, lipoxins, and protectins, are capable of inhibiting the pro-inflammatory MIF, IL-2, IL-6, TNF-a, and HMGB1, thus inhibiting inflammation in autoimmune diseases such as rheumatoid arthritis and SLE […”
InfluentialOuarrat, D. E., Isaac, R., Lee, Y. S., Oh, D. Y., Wollam, J., Lackey, D. E., Riopel, M., Bandyopadhyay, G. K., Seo, J. B., Sampath-Kumar, R., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.003 · Cited by 104
Self-citationKatsimbri, P., Korakas, E., Kountouri, A., Ikonomidis, I., Tsougos, E., Vlachos, D., Papadavid, E., Raptis, A. E., & Lambadiari, V. (2021) · Antioxidants · doi:10.3390/antiox10020157 · Cited by 114
“Omega-3 FAs’ anti-inflammatory effects are mainly attributed to the interaction with the G-protein coupled receptor 120 (GPR120), expressed on macrophages, which leads to decreased TLR4-dependent and LPS-mediated cyclooxygenase-2 (COX-2) activation and subsequent prostaglandin release [39], while another action on mac…”
Valenzuela, R., Espinosa, A., Gonzalez‐Mañán, D., D’Espessailles, A., Fernández, V., Videla, L. A., & Tapia, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046400 · Cited by 107
Oliveira, V., Marinho, R., Vitorino, D., Santos, G. A., Moraes, J. C., Dragano, N., Sartori-Cintra, A., Pereira, L., Catharino, R. R., da Silva, A. S. R., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1880 · Cited by 102
Lankinen, M. A., Schwab, U., Kolehmainen, M., Paananen, J., Poutanen, K. S., Mykkänen, H. M., Seppänen‐Laakso, T., Gylling, H. K., Uusitupa, M. I. J., & Orešič, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022646 · Cited by 105
Free Fatty Acids-Sensing G Protein-Coupled Receptors in Drug Targeting and Therapeutics
Yonezawa, T., Kurata, R., Yoshida, K., Murayama, M. A., Cui, X., & Hasegawa, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990168 · Cited by 104
Ohue‐Kitano, R., Watanabe‐Yasuoka, Y., Goto, T., Kitamura, N., Park, S., Kishino, S., Kimura, I., Kasubuchi, M., Takahashi, H., Li, Y., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700273r · Cited by 105
Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages
Im, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.094 · Cited by 104
Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch
Ji, R. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-084047 · Cited by 109
Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
Russell, F. D., & Bürgin-Maunder, C. (2012) · Marine Drugs · doi:10.3390/md10112535 · Cited by 106
Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity
Azevedo, C. M. G., Watterson, K. R., Wargent, E. T., Hansen, S. V. F., Hudson, B. D., Kępczyńska, M. A., Dunlop, J., Shimpukade, B., Christiansen, E., Milligan, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00685 · Cited by 102
Jama, H. A., Beale, A. L., Shihata, W., & Marques, F. Z. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz091 · Cited by 105
Insulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 105
Sukumar, P., Sedó, A., Li, J., Wilson, L. A., O'Regan, D., Lippiat, J. D., Porter, K. E., Kearney, M. T., Ainscough, J., & Beech, D. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.270751 · Cited by 101
Liu, Z., Hopkins, M. M., Zhang, Z., Quisenberry, C. B., Fix, L. C., Galvan, B. M., & Meier, K. E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218974 · Cited by 100
Huang, C., Chien, Y.-S., Chen, Y.-J., Ajuwon, K. M., Mersmann, H. J., & Ding, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101689 · Cited by 107
Schilperoort, M., van Dam, A. D., Hoeke, G., Shabalina, I. G., Okolo, A., Hanyaloglu, A. C., Dib, L. H., Mol, I. M., Caengprasath, N., Chan, Y., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708047 · Cited by 100
Omega-3 fatty acids and adipose tissue biology
Kuda, O., Rossmeisl, M., & Kopecký, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.004 · Cited by 103
The role of GPCRs in bone diseases and dysfunctions
Luo, J., Sun, P., Siwko, S. K., Liu, M., & Xiao, J. (2019) · Bone Research · doi:10.1038/s41413-019-0059-6 · Cited by 102
de Bus, I., Witkamp, R. F., Zuilhof, H. T., Albada, B., & Balvers, M. G. J. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106351 · Cited by 105
Opreanu, M., Tikhonenko, M., Bozack, S. N., Lydic, T. A., Reid, G. E., McSorley, K. M., Sochacki, A. L., Perez, G. I., Esselman, W. J., Kern, T. S., et al. (2011) · Diabetes · doi:10.2337/db10-0550 · Cited by 99
Omega 3 Fatty Acids and GPR120
Oh, D. Y., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.009 · Cited by 100
Self-citationSawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., Yamashita, S., Oishi, S., Osue, T., Yokoi, K., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0437-y · Cited by 97
Zhou, J., Xu, G., Ma, S., Li, F., Yuan, M., Xu, H., & Huang, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.054 · Cited by 97
Marine omega-3 fatty acids and coronary heart disease
Calder, P. C., & Yaqoob, P. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328353febd · Cited by 99
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 107
Ghanbari, M., Maragheh, S. M., Aghazadeh, A., Mehrjuyan, S. R., Hussen, B. M., Shadbad, M. A., Dastmalchi, N., & Safaralizadeh, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107765 · Cited by 101
The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases
Cambiaggi, L., Chakravarty, A., Noureddine, N., & Hersberger, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076110 · Cited by 108
Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies
Elkanawati, R. Y., Sumiwi, S. A., & Levita, J. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s468147 · Cited by 110
Li, Z., Xu, X. J., Huang, W., & Qian, H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21441 · Cited by 97
Melhem, H., Kaya, B., Ayata, C. K., Hruz, P. L., & Niess, J. H. (2019) · Cells · doi:10.3390/cells8050450 · Cited by 96
“Additionally, GPR120 was detectable in macrophages, adipocytes and type II taste cells [105,115,116].”
Mechanisms of Omega-3 Polyunsaturated Fatty Acids in Prostate Cancer Prevention
Gu, Z., Suburu, J., Chen, H., & Chen, Y. Q. (2013) · BioMed Research International · doi:10.1155/2013/824563 · Cited by 96
Bo, L., Jiang, S., Xie, Y., Kan, H., Song, W., & Zhao, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152216 · Cited by 99
Joseph, J., Depp, C. A., Shih, P.-A. B., Cadenhead, K. S., & Schmid‐Schönbein, G. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95
Ajmone‐Cat, M. A., Salvatori, M. L., Simone, R. D., Mancini, M., Biagioni, S., Bernardo, A., Cacci, E., & Minghetti, L. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22783 · Cited by 99
楠知里, Liu, Y., Yoshizaki, T., Nakagawa, F., Ishikado, A., Kondo, M., Morino, K., Sekine, O., Ugi, S., Nishio, Y., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.115 · Cited by 95
Han, J., Kim, I., Jung, S., Lee, S.-G., Son, H., & Myung, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095268 · Cited by 96
Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice
Suckow, A. T., Polidori, D., Yan, W., Chon, S., Jing, Y., Leonard, J. N., & Briscoe, C. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568683 · Cited by 94
Meital, L. T., Windsor, M., Perissiou, M., Schulze, K., Magee, R., Kuballa, A., Golledge, J., Bailey, T. G., Askew, C. D., & Russell, F. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-49362-z · Cited by 94
Valenzuela, R., & Videla, L. A. (2020) · Nutrients · doi:10.3390/nu12020499 · Cited by 97
Bachmann, M. C., Bellalta, S., Basoalto, R., Gómez‐Valenzuela, F., Jalil, Y., Lépez, M., Matamoros, A., & Rommy von Bernhardi, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570083 · Cited by 102
“7 cells and of primary intraperitoneal macrophages (105).”
Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook
Mahri, S. A., Malik, S. S., Ibrahim, M. A., Haji, E. M., Dairi, G., & Mohammad, S. (2022) · Cells · doi:10.3390/cells11040750 · Cited by 99
Nagasaki, H., Kondo, T., Fuchigami, M., Hashimoto, H., Sugimura, Y., Ozaki, N., Arima, H., Ota, A., Oiso, Y., & Hamada, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.001 · Cited by 99
An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids
Yanai, H., Masui, Y., Katsuyama, H., Adachi, H., Kawaguchi, A., Hakoshima, M., Waragai, Y., Harigae, T., & Sako, A. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3362w · Cited by 98
Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism
Caesar, R., Nygrén, H., Orešič, M., & Bäckhed, F. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m065847 · Cited by 94
Polyunsaturated Fatty Acid Biosynthesis and Metabolism in Fish
Monroig, Ó., Tocher, D. R., & Castro, L. F. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811230-4.00003-x · Cited by 95
Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules
Das, U. N. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.11.009 · Cited by 94
Samimi, M., Jamilian, M., Asemi, Z., & Esmaillzadeh, A. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.06.005 · Cited by 95
Retracted
Metadata
- Authors
- Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Shiga University of Medical Science (JP)
- Corresponding author
- Olefsky, Jerrold M.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 142
- Issue
- 5
- Pages
- 687-698
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2956412
- OpenAlex
- W2131094572
- Cited by
- 2,428
- References
- 49
- Citations by year
- 2026: 97 · 2025: 134 · 2024: 123 · 2023: 129 · 2022: 134 · 2021: 180 · 2020: 172 · 2019: 157 · 2018: 158 · 2017: 181 · 2016: 197 · 2015: 177 · 2014: 165 · 2013: 162 · 2012: 143
- FWCI
- 127.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (NIDDK DK033651, DK 074868, DK063491, U54 HD 012303-25)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- GPR120, docosahexaenoic acid, eicosapentaenoic acid, anti-inflammatory activity, insulin sensitivity, insulin resistance, macrophage inflammation, obesity, high-fat diet, G protein-coupled receptors, RAW 264.7 macrophages
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Line, Dietary Fats, Humans, Hypoglycemic Agents, Insulin Resistance, Macrophages, Obesity, Fatty Acids, Omega-3, Mice, Knockout, Dietary Supplements, 3T3-L1 Cells, Receptors, G-Protein-Coupled, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review